CLS (LON:CLI – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Berenberg Bank in a note issued to investors on Tuesday,London Stock Exchange reports. They presently have a GBX 58 price objective on the stock. Berenberg Bank’s target price would indicate a potential upside of 22.60% from the stock’s previous close.
CLS Price Performance
Shares of CLI opened at GBX 47.31 on Tuesday. The company has a quick ratio of 0.59, a current ratio of 0.29 and a debt-to-equity ratio of 121.99. CLS has a twelve month low of GBX 45.30 and a twelve month high of GBX 67. The stock has a market capitalization of £188.35 million, a P/E ratio of -3.75 and a beta of 1.00. The company has a 50 day moving average of GBX 49.31 and a 200-day moving average of GBX 52.37.
Insider Buying and Selling
In other CLS news, insider Fredrik Widlund purchased 20,109 shares of the stock in a transaction on Wednesday, May 27th. The shares were purchased at an average price of GBX 46 per share, with a total value of £9,250.14. Insiders own 60.13% of the company’s stock.
CLS Company Profile
We are a commercial property investment company with a £2.1bn portfolio listed on the Premium Main Market on the London Stock Exchange, specialising in future-focused office space in the UK, Germany and France. Through geographical diversification, local expertise and an active management approach, we transform office properties into sustainable, modern spaces that help our tenants’ businesses to grow.
Further Reading
- Five stocks we like better than CLS
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.
